Spencer Feldman

A gynecologic oncologist on the testing that shapes treatment, the side effect not to push through and why fertility questions can't wait.

The FDA granted accelerated approval to Zenbexus with daratumumab and hyaluronidase-fihj and dexamethasone for previously treated multiple myeloma.

Nicole Schulz was 14 when she received an AML diagnosis. She shares what carried her through two transplants and 11 months in the hospital.

A multiple myeloma survivor and advocate answers the questions people ask most after a diagnosis, from maintenance therapy to stem cell transplant.

An oncologist explains why the choice between removing one lobe or the whole thyroid should be a conversation, not a surprise.

Dr. Robert S. Alter discusses what to ask before thyroid surgery, why "active surveillance" isn't passive and how targeted therapy is changing outcomes.

Dr. Mark Zhao explains how minimally invasive techniques preserve function, speed recovery and why patients should not wait years to raise bowel symptoms with their doctor.

The 10-3 vote came during a discussion in which the limitations of TIL therapy, the only approved option for this group of patients, were raised repeatedly.

Serene Hesri was 25 when Hodgkin lymphoma was diagnosed. After relapsing, she enrolled in a clinical trial — and has been in remission for five years.

Dr. Mark Zhao of UCSF Health discusses how TAMIS and single-port robotic surgery give select rectal cancer patients less invasive care and faster recovery.

Serene Hesri was diagnosed with Hodgkin's lymphoma at 25. After a relapse, she enrolled in a clinical trial — and hasn't looked back since.

Biomarker testing looks for genes, proteins and other markers in your cancer that can help your care team choose the most effective treatment for you.

As Canadian wildfire smoke blankets much of the U.S., here's what people with cancer and cancer survivors should know about the potential health risks.

The FDA upgraded its approval of Retevmo for adults and children 2 and older with RET fusion-positive solid tumors.

Learn what angioimmunoblastic T-cell lymphoma is, how it's staged, how each stage is treated and what survivorship looks like.

In a glioblastoma phase I trial, repeated brain injections of modified immune cells doubled progression-free survival to 16.1 months versus 8 months.

Partnering with Lilly on a clinical trial awareness campaign, the actor reflects on his grandmother's record-setting survival and the simple message he wants every patient to hear.

AURORA, a phase 3 trial, is testing aglatimagene besadenovec plus Keytruda in patients with lung cancer who progressed on immunotherapy.

14 years after a rare lymphoma diagnosis, Edward Miskie answers real questions on survivorship, caregiving and life after cancer treatment.

EHA 2026 brought new data on myeloma, leukemia and lymphoma. Here's what patients and caregivers should know about five key studies.

Tammy Zinn, a finalist for the Extraordinary Healer Award, reflects on the personal loss that led her to oncology nursing and the programs she built to support patients.

In a Q&A with CURE, oncology nurse Jill Winther reflects on advocacy, holistic care, and what's kept her in the field for 35 years.

Oncology nurse Tammy Zinn, an Extraordinary Healer finalist, discusses hope, advocacy, and launching Emma's Wish for patients with cancer.

Oncology nurse Jill Winther discusses why understanding treatment reasoning and advocating for patients matters most in cancer care.

10 Things That Got Me Through Treatment ft. Kiana Wooten

After surviving breast cancer and relapsed non-Hodgkin lymphoma, Maitte Penalver is helping Hispanic patients with cancer feel seen, heard and supported through advocacy and education.

Survivorship coach Eileen Lopez Tomei discusses the unique cultural barriers Hispanic and Latina cancer survivors face and why bilingual community events matter.

After a stage 4 colon cancer diagnosis at age 40, survivor Kasia Orzechowska now advocates for early screening and self-advocacy to help save lives.

Psychologist Ian Sadler explains why many patients with cancer face anxiety and emotional challenges after treatment ends and why mental health support matters.

Mariska Hargitay discusses her father's myeloma, hope from research and the importance of community and caregivers for patients.